Clinical Trial Update: A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update evaluating safety and efficacy of TQB2450 with Anlotinib in advanced biliary adenocarcinoma and hepatocellular carcinoma across Phase 1 an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Adenocarcinoma
• Hepatocellular Carcinoma

Drugs mentioned

• Anlotinib (anlotinib)
• TQB2450

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN